{"id":"W4413127968","doi":"10.51731/cjht.2025.1189","title":"Quizartinib (Vanflyta)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002683684,0.0002743048,0.0004867275,0.0006691397,0.0004067105,0.0008179671,0.0005553769,0.0006890781,0.01982531],"category_scores_gemma":[0.0004434733,0.000128188,0.0003815099,0.0003912229,0.0001741958,0.0003766061,0.0004136188,0.001110183,0.00607866],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001627456,"about_ca_system_score_gemma":0.00150768,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007756079,"about_ca_topic_score_gemma":0.02206332,"domain_scores_codex":[0.9997993,0.00002041214,0.00001367944,0.00003403861,0.00007047331,0.00006213521],"domain_scores_gemma":[0.999878,0.00001017052,0.00002026141,0.000008235598,0.00003263065,0.00005063468],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002525946,0.0006213124,0.002994473,0.001021687,0.0001586352,0.0006944477,0.00004748411,0.0009487254,0.01414998,0.004352968,0.2911105,0.6813739],"study_design_scores_gemma":[0.005088936,0.002139945,0.01286543,0.0005333706,0.0002089289,0.005358096,0.00005926238,0.002186613,0.01475746,0.001716252,0.9550297,0.00005605565],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.2154652,0.1920052,0.006700764,0.03281097,0.00457741,0.001997437,0.02174399,0.006080692,0.5186183],"genre_scores_gemma":[0.7482355,0.04121261,0.006062521,0.01188052,0.0006533377,0.0005733001,0.02431941,0.0001614572,0.1669012],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.01982531,"threshold_uncertainty_score":0.06632227,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02237752274608368,"score_gpt":0.3158917955807999,"score_spread":0.2935142728347162,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}